Rare diseases
Investigational molecules
Locations
Back to Italy43 clinical trials in Brindisi, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Avelumab for Patients with High-Risk Triple Negative Breast Cancer
ItalyStudy on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia
ItalyStudy on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
ItalyStudy Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments
ItalyStudy on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on Bevacizumab and Erlotinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
ItalyStudy on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients
ItalyStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
ItalyStudy of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery
ItalyStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
ItalyStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Acute Myeloid Leukemia and Follicular Lymphoma, investigating new therapeutic approaches including targeted treatments and immunotherapy combinations.
Research aims to improve treatment outcomes and patient survival rates through personalized therapeutic strategies.
Comprehensive studies on various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease variants.
Investigations aim to enhance treatment efficacy through targeted therapies and precision medicine approaches.
Advanced research in ovarian cancer and related conditions, with particular emphasis on maintenance therapies and biomarker-driven treatment approaches.
Studies focus on improving progression-free survival and identifying effective treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
